Using extended half-life products cuts bleeds in hemophilia B kids
Using longer-acting factor IX (FIX) products — known as extended half-life (EHL) products, or EHL-FIX — safely reduced factor use…
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as a scientific writer in 2022. Outside of work, she enjoys street photography, mountain hikes, running, and spending as much time outdoors as possible.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Using longer-acting factor IX (FIX) products — known as extended half-life (EHL) products, or EHL-FIX — safely reduced factor use…
People with hemophilia A and their caregivers, as well as healthcare providers, have shown a strong interest in a…
Hemlibra (emicizumab-kxwh) safely supports joint health in children with hemophilia A without inhibitors through three years of treatment,…
In people with hemophilia A, certain immune markers in the blood may help predict patient responses to immune tolerance…
People with hemophilia A in China see major health challenges, such as frequent joint bleeding, joint malformation, and high…
A lack of family history of disease can delay a diagnosis and timely initiation of preventive therapy in children with…
Get regular updates to your inbox.